Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years
Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell and Gene Therapy CROs Market, 2022-2035”.
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
- A detailed overview of the overall market landscape of the cell and gene therapy CROs, based on several relevant parameters, such as year of establishment, company size, location of headquarters, area of expertise, scale of operation and types of services offered.
- A detailed analysis on the business models that are commonly adopted by the biopharmaceutical industry for outsourcing cell and gene therapies.
- Elaborate profiles of key industry players based in North America, Europe and Asia-Pacific that offer contract research services.
- A benchmark analysis of the various players engaged in this domain. It highlights the capabilities of the companies.
- An analysis of the recent collaborations within the cell and gene therapy contract research industry, during the period 2015-2022.
- A detailed analysis of the various mergers and acquisitions that have taken place in this domain, during the period 2015-2022.
- A detailed acquisition target analysis, taking into consideration historical trend of the activity of players that have acquired other firms since 2015.
- A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution highlighting the relative effect of each SWOT parameter on the overall cell and gene therapies research services industry.
- A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
- Area of Expertise
- Cell Therapy
- Gene Therapy
- Scale of Operation
- Preclinical
- Clinical
- Drug Discovery
- Therapeutic Area
- Oncological Disorders
- Neurological Disorders
- Cardiovascular Disorders
- Infectious Diseases
- Metabolic Disorders
- Autoimmune Disorders
- Blood Disorders
- Rare / Genetic Disorders
- Ophthalmic Disorders
- Other disorders
- Analysis by Geographical Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and North Africa
Key companies covered in the report
- Altasciences
- Charles River Laboratories
- Creative Biolabs
- IQVIA
- Medpace
- PPD
- Precision for Medicine
- Accelera
- Evotec
- ICON
- Syneos Health
- CMIC Group
- Labcorp
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html
News article
AI-based digital pathology market
Learn from experts: do you know about these emerging industry trends?
TCR Therapies: An Emerging Therapeutic Modality
Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
